To identify human microbiota species associated with oncohematological diseases
To identify mechanisms of colonization resistance thorough metratransciptomic, metaproteomic, metabolomics assays, among others
To identify the potential relationship between the use of antibiotics, biodiversity of the microbiota and colonization / infection by opportunistic pathogens.
To study the effect of probiotics administration in hematological patients
